JAPANESE JOURNAL OF CLINICAL ONCOLOGY, vol.35, no.5, pp.239-244, 2005 (SCI-Expanded)
Background: We designed a phase II trial for evaluation of the efficacy and tolerability of an accelerated concomitant boost radiotherapy scheme for the treatment of the patients with non-small cell lung cancer (NSCLC).